Among AIMBE’s most important roles is the promotion of public policies that foster continued advancement in medical and biological engineering (MBE). We educate and influence public officials, regulators, the media and general public about the positive impact MBE has on virtually every sector of society – from human health to a vibrant economy. AIMBE advocates for legislative, monetary and regulatory solutions that assistant our engineering community at each stage of the innovation ecosystem – from the research lab to the bedside of a patient.
• Showcasing Biotech Innovations on Capitol Hill. AIMBE highlights the importance of federal funding by providing Congressional staff with live biomedical technology demonstrations from 8 teams of researchers through an interactive exhibition in the U.S. House of Representatives.
• AIMBE Congressional Lunch Briefings. Each year, AIMBE hosts a series of Congressional Lunch Briefings for Members of Congress and their staff highlighting ground-breaking medical and biological engineering research conducted by Fellows.
• AIMBE Congressional Staff Tours of FDA. This tour, and AIMBE’s congressional tours of NIH, are part of AIMBE’s expanded advocacy efforts to inform key House and Senate staffers about the role of federal funding for medical device innovation, from the early stages of discovery funded by NIH, to regulatory approval by FDA.
• University Public Policy Lecture Series. AIMBE has launched a new lecture series on the campuses of colleges and universities across the country to discuss Congress and medical and biological engineering.
• AIMBE Joins Congressional Research and Development Caucus Advisory Committee. In this role, AIMBE helps to bring important issues to the attention of Congress by shaping briefings and hearings for Members and their staff.
• AIMBE Congressional Staff Tours of NIH. AIMBE provides Congressional staff with their first look inside the NIH, witnessing cutting-edge bioengineering technologies first-hand at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) – the largest Congressional event the NIH has seen to date!
• Making the Case for Public Investments in Medical Technology. An AIMBE Voice opinion paper published by Science Translational Medicine argues Americans have always embraced innovation but today there is a failure in making the case for public investments in medical-technology.
• AIMBE Storms the Hill to Advocate for MBE. Each year during AIMBE’s Annual Event, Fellows from across the country travel to Washington, DC to meet with their Representatives and Senators to advocate the positive impact medical and biological engineering has on society.
• Educating Graduate Students about Public Policy. AIMBE hosts a 2-day Public Policy Institute for graduate students to learn from Washington insiders about how public policies and appropriations directly impact scientific discovery, research, and medical innovation. Participants hear from policy experts, industry leaders, and senior government officials about the policy landscape shaping the scientific enterprise.